3. BENIGN DISORDERS
3.1 ACHLASIA CARDIA
There is in this
disorder a failure of relaxation of
the lower
end of the oesophagus (LES).
- The etiology is
unknown.
- There is
evidence of vagus nerve dysfunction and an observed
change in
morphology and number of oesophageal ganglion cells
of Auerbach's plexus. There is progressive dilation of the
oesophagus
- The presenting
symptoms of this disorder are food sticking and
patients using
fluids to wash down the food.
- The
sticking or dysphagia may be referred to
the suprasternal
notch and may be
made worse by stress.
- There may also
be a complaint of regurgitation or eructation
of foul odour.
- In cases there
is a loss of weight.
- Pulmonary complication occur because of aspiration pneumonia
and include lung
abscess, bronciectasis and haemoptysis.
Diagnosis is established
with a barium
study which shows
dilation,
tortuosity of proximal esophagus
and bird beak like
narrowing of the terminal portion of the oesophagus Roesophagus
copy is indicated to rule out oesophagitis and carcinoma
Esophageal
manometry remains best for diagnosing achalasia, absent peristalsis in the
distal smooth muscle segment of the esophagus with incomplete LES relaxation.
In cases of manometric finding of normal esophageal motility an aggressive
search for a tumor must be undertaken.
Treatment is surgical and involves an incision into
the muscular
coat of the terminal portion of narrow
oesophagus leaving the
mucosa intact (oesophagomyotomy) (Fig. above.
Dilation with
hydrostatic
or pneumatic dilators
can be tried.
Use of
nitroglycerin sublingual can provide temporary relief of
swollowing
difficulty
The
drugs used to treat patients with achalasia have been smooth muscle relaxatnts
aimed at decreasing LES tone, are calcium channel blockers (nifedipine,
verapamil), opiods (loperamide), nitrates (isorsorbide dinitrate), and
anticholinergics (cimetropium bromide) pharmacotherapy is best reserved as an
adjunct to other therapies.
Botulinum
toxin (BoTox) is a potent inhibitor of acetylcholine release form presynaptic
nerve terminals. Recently, BoTox endoscopically injected into the LES has been
used in the management of achalasia to decrease resting LES tone.
Heartburn
relieve ingesting antacid regurgitation dysphagia.
Short
term treatment acid suppression regimens effectively relieve symptoms
Any questions be sent to drmmkapur@gmail.com
All older posts are stored in archives for access and review
Visitors that follow may post contributions to the site.
To create consumer/provider engagement visit www.drmmkapur.blogspot.com
www.otmanage.blogspot.com